Insider Selling: Hologic, Inc. (NASDAQ:HOLX) Insider Sells 2,570 Shares of Stock

Hologic, Inc. (NASDAQ:HOLX) insider Benjamin Jordan Cohn sold 2,570 shares of the company’s stock in a transaction on Friday, November 19th. The stock was sold at an average price of $75.79, for a total transaction of $194,780.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of HOLX stock opened at $74.91 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 2.01 and a current ratio of 2.39. The firm’s 50-day moving average is $72.86 and its 200-day moving average is $71.05. The stock has a market cap of $18.83 billion, a price-to-earnings ratio of 10.40, a PEG ratio of 1.57 and a beta of 1.12. Hologic, Inc. has a 52-week low of $60.10 and a 52-week high of $85.00.

Hologic (NASDAQ:HOLX) last issued its earnings results on Sunday, October 31st. The medical equipment provider reported $1.61 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.01 by $0.60. Hologic had a net margin of 33.22% and a return on equity of 57.61%. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.04 billion. During the same period in the prior year, the firm earned $2.07 EPS. Hologic’s quarterly revenue was down 2.3% compared to the same quarter last year. Sell-side analysts predict that Hologic, Inc. will post 3.7 EPS for the current fiscal year.

Several equities research analysts have commented on HOLX shares. Raymond James boosted their price target on shares of Hologic from $78.00 to $88.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 3rd. William Blair reissued an “outperform” rating on shares of Hologic in a research report on Tuesday, November 2nd. Morgan Stanley boosted their price target on shares of Hologic from $75.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 2nd. Jefferies Financial Group started coverage on shares of Hologic in a research report on Thursday, July 29th. They set a “buy” rating and a $95.00 price target on the stock. Finally, Redburn Partners started coverage on shares of Hologic in a research report on Thursday, October 14th. They set a “neutral” rating on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average target price of $85.83.

Several large investors have recently made changes to their positions in HOLX. Clean Yield Group acquired a new position in shares of Hologic during the 2nd quarter worth approximately $25,000. Private Capital Group LLC lifted its stake in Hologic by 117.7% in the 3rd quarter. Private Capital Group LLC now owns 418 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 226 shares during the last quarter. CX Institutional lifted its stake in Hologic by 38.1% in the 2nd quarter. CX Institutional now owns 602 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 166 shares during the last quarter. Dark Forest Capital Management LP bought a new position in Hologic in the 3rd quarter valued at approximately $40,000. Finally, Total Clarity Wealth Management Inc. bought a new position in Hologic in the 3rd quarter valued at approximately $53,000. Hedge funds and other institutional investors own 90.93% of the company’s stock.

About Hologic

Hologic, Inc engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a portfolio of solutions for breast cancer care for radiology, pathology, and surgery.

See Also: The mechanics of the bid-ask spread in trading

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.